Global Human Immune Globulin Intravenous Market Research Report 2024(Status and Outlook)
Report Overview
Immune globulin(Ig) short-term protection against hepatitis A and measles
This report provides a deep insight into the global Immune Globulin Intravenous market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Immune Globulin Intravenous Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Immune Globulin Intravenous market in any manner.
Global Immune Globulin Intravenous Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Market Segmentation (by Type)
IVIg Liquid
IVIg Powder
Market Segmentation (by Application)
Immunodeficiency
Autoimmune Disease
Acute Infection
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immune Globulin Intravenous Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Immune globulin(Ig) short-term protection against hepatitis A and measles
This report provides a deep insight into the global Immune Globulin Intravenous market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Immune Globulin Intravenous Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Immune Globulin Intravenous market in any manner.
Global Immune Globulin Intravenous Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Takeda
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Market Segmentation (by Type)
IVIg Liquid
IVIg Powder
Market Segmentation (by Application)
Immunodeficiency
Autoimmune Disease
Acute Infection
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Immune Globulin Intravenous Market
- Overview of the regional outlook of the Immune Globulin Intravenous Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immune Globulin Intravenous Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Human Immune Globulin Intravenous
1.2 Key Market Segments
1.2.1 Human Immune Globulin Intravenous Segment by Type
1.2.2 Human Immune Globulin Intravenous Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN IMMUNE GLOBULIN INTRAVENOUS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Immune Globulin Intravenous Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Human Immune Globulin Intravenous Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN IMMUNE GLOBULIN INTRAVENOUS MARKET COMPETITIVE LANDSCAPE
3.1 Global Human Immune Globulin Intravenous Sales by Manufacturers (2019-2024)
3.2 Global Human Immune Globulin Intravenous Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Immune Globulin Intravenous Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Immune Globulin Intravenous Sales Sites, Area Served, Product Type
3.6 Human Immune Globulin Intravenous Market Competitive Situation and Trends
3.6.1 Human Immune Globulin Intravenous Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Immune Globulin Intravenous Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HUMAN IMMUNE GLOBULIN INTRAVENOUS INDUSTRY CHAIN ANALYSIS
4.1 Human Immune Globulin Intravenous Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN IMMUNE GLOBULIN INTRAVENOUS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HUMAN IMMUNE GLOBULIN INTRAVENOUS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Immune Globulin Intravenous Sales Market Share by Type (2019-2024)
6.3 Global Human Immune Globulin Intravenous Market Size Market Share by Type (2019-2024)
6.4 Global Human Immune Globulin Intravenous Price by Type (2019-2024)
7 HUMAN IMMUNE GLOBULIN INTRAVENOUS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Immune Globulin Intravenous Market Sales by Application (2019-2024)
7.3 Global Human Immune Globulin Intravenous Market Size (M USD) by Application (2019-2024)
7.4 Global Human Immune Globulin Intravenous Sales Growth Rate by Application (2019-2024)
8 HUMAN IMMUNE GLOBULIN INTRAVENOUS MARKET SEGMENTATION BY REGION
8.1 Global Human Immune Globulin Intravenous Sales by Region
8.1.1 Global Human Immune Globulin Intravenous Sales by Region
8.1.2 Global Human Immune Globulin Intravenous Sales Market Share by Region
8.2 North America
8.2.1 North America Human Immune Globulin Intravenous Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Immune Globulin Intravenous Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Immune Globulin Intravenous Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Immune Globulin Intravenous Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Immune Globulin Intravenous Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Takeda
9.1.1 Takeda Human Immune Globulin Intravenous Basic Information
9.1.2 Takeda Human Immune Globulin Intravenous Product Overview
9.1.3 Takeda Human Immune Globulin Intravenous Product Market Performance
9.1.4 Takeda Business Overview
9.1.5 Takeda Human Immune Globulin Intravenous SWOT Analysis
9.1.6 Takeda Recent Developments
9.2 Grifols
9.2.1 Grifols Human Immune Globulin Intravenous Basic Information
9.2.2 Grifols Human Immune Globulin Intravenous Product Overview
9.2.3 Grifols Human Immune Globulin Intravenous Product Market Performance
9.2.4 Grifols Business Overview
9.2.5 Grifols Human Immune Globulin Intravenous SWOT Analysis
9.2.6 Grifols Recent Developments
9.3 CSL
9.3.1 CSL Human Immune Globulin Intravenous Basic Information
9.3.2 CSL Human Immune Globulin Intravenous Product Overview
9.3.3 CSL Human Immune Globulin Intravenous Product Market Performance
9.3.4 CSL Human Immune Globulin Intravenous SWOT Analysis
9.3.5 CSL Business Overview
9.3.6 CSL Recent Developments
9.4 Octapharma
9.4.1 Octapharma Human Immune Globulin Intravenous Basic Information
9.4.2 Octapharma Human Immune Globulin Intravenous Product Overview
9.4.3 Octapharma Human Immune Globulin Intravenous Product Market Performance
9.4.4 Octapharma Business Overview
9.4.5 Octapharma Recent Developments
9.5 Biotest
9.5.1 Biotest Human Immune Globulin Intravenous Basic Information
9.5.2 Biotest Human Immune Globulin Intravenous Product Overview
9.5.3 Biotest Human Immune Globulin Intravenous Product Market Performance
9.5.4 Biotest Business Overview
9.5.5 Biotest Recent Developments
9.6 Kedrion
9.6.1 Kedrion Human Immune Globulin Intravenous Basic Information
9.6.2 Kedrion Human Immune Globulin Intravenous Product Overview
9.6.3 Kedrion Human Immune Globulin Intravenous Product Market Performance
9.6.4 Kedrion Business Overview
9.6.5 Kedrion Recent Developments
9.7 Hualan Bio
9.7.1 Hualan Bio Human Immune Globulin Intravenous Basic Information
9.7.2 Hualan Bio Human Immune Globulin Intravenous Product Overview
9.7.3 Hualan Bio Human Immune Globulin Intravenous Product Market Performance
9.7.4 Hualan Bio Business Overview
9.7.5 Hualan Bio Recent Developments
9.8 CNBG
9.8.1 CNBG Human Immune Globulin Intravenous Basic Information
9.8.2 CNBG Human Immune Globulin Intravenous Product Overview
9.8.3 CNBG Human Immune Globulin Intravenous Product Market Performance
9.8.4 CNBG Business Overview
9.8.5 CNBG Recent Developments
9.9 Shanghai RAAS
9.9.1 Shanghai RAAS Human Immune Globulin Intravenous Basic Information
9.9.2 Shanghai RAAS Human Immune Globulin Intravenous Product Overview
9.9.3 Shanghai RAAS Human Immune Globulin Intravenous Product Market Performance
9.9.4 Shanghai RAAS Business Overview
9.9.5 Shanghai RAAS Recent Developments
9.10 CBPO
9.10.1 CBPO Human Immune Globulin Intravenous Basic Information
9.10.2 CBPO Human Immune Globulin Intravenous Product Overview
9.10.3 CBPO Human Immune Globulin Intravenous Product Market Performance
9.10.4 CBPO Business Overview
9.10.5 CBPO Recent Developments
9.11 LFB Group
9.11.1 LFB Group Human Immune Globulin Intravenous Basic Information
9.11.2 LFB Group Human Immune Globulin Intravenous Product Overview
9.11.3 LFB Group Human Immune Globulin Intravenous Product Market Performance
9.11.4 LFB Group Business Overview
9.11.5 LFB Group Recent Developments
9.12 BPL
9.12.1 BPL Human Immune Globulin Intravenous Basic Information
9.12.2 BPL Human Immune Globulin Intravenous Product Overview
9.12.3 BPL Human Immune Globulin Intravenous Product Market Performance
9.12.4 BPL Business Overview
9.12.5 BPL Recent Developments
9.13 Sichuan Yuanda Shuyang
9.13.1 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Basic Information
9.13.2 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product Overview
9.13.3 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product Market Performance
9.13.4 Sichuan Yuanda Shuyang Business Overview
9.13.5 Sichuan Yuanda Shuyang Recent Developments
10 HUMAN IMMUNE GLOBULIN INTRAVENOUS MARKET FORECAST BY REGION
10.1 Global Human Immune Globulin Intravenous Market Size Forecast
10.2 Global Human Immune Globulin Intravenous Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Immune Globulin Intravenous Market Size Forecast by Country
10.2.3 Asia Pacific Human Immune Globulin Intravenous Market Size Forecast by Region
10.2.4 South America Human Immune Globulin Intravenous Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Immune Globulin Intravenous by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Human Immune Globulin Intravenous Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Human Immune Globulin Intravenous by Type (2025-2030)
11.1.2 Global Human Immune Globulin Intravenous Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Human Immune Globulin Intravenous by Type (2025-2030)
11.2 Global Human Immune Globulin Intravenous Market Forecast by Application (2025-2030)
11.2.1 Global Human Immune Globulin Intravenous Sales (Kilotons) Forecast by Application
11.2.2 Global Human Immune Globulin Intravenous Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Human Immune Globulin Intravenous
1.2 Key Market Segments
1.2.1 Human Immune Globulin Intravenous Segment by Type
1.2.2 Human Immune Globulin Intravenous Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN IMMUNE GLOBULIN INTRAVENOUS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Immune Globulin Intravenous Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Human Immune Globulin Intravenous Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN IMMUNE GLOBULIN INTRAVENOUS MARKET COMPETITIVE LANDSCAPE
3.1 Global Human Immune Globulin Intravenous Sales by Manufacturers (2019-2024)
3.2 Global Human Immune Globulin Intravenous Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Immune Globulin Intravenous Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Immune Globulin Intravenous Sales Sites, Area Served, Product Type
3.6 Human Immune Globulin Intravenous Market Competitive Situation and Trends
3.6.1 Human Immune Globulin Intravenous Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Immune Globulin Intravenous Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HUMAN IMMUNE GLOBULIN INTRAVENOUS INDUSTRY CHAIN ANALYSIS
4.1 Human Immune Globulin Intravenous Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN IMMUNE GLOBULIN INTRAVENOUS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HUMAN IMMUNE GLOBULIN INTRAVENOUS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Immune Globulin Intravenous Sales Market Share by Type (2019-2024)
6.3 Global Human Immune Globulin Intravenous Market Size Market Share by Type (2019-2024)
6.4 Global Human Immune Globulin Intravenous Price by Type (2019-2024)
7 HUMAN IMMUNE GLOBULIN INTRAVENOUS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Immune Globulin Intravenous Market Sales by Application (2019-2024)
7.3 Global Human Immune Globulin Intravenous Market Size (M USD) by Application (2019-2024)
7.4 Global Human Immune Globulin Intravenous Sales Growth Rate by Application (2019-2024)
8 HUMAN IMMUNE GLOBULIN INTRAVENOUS MARKET SEGMENTATION BY REGION
8.1 Global Human Immune Globulin Intravenous Sales by Region
8.1.1 Global Human Immune Globulin Intravenous Sales by Region
8.1.2 Global Human Immune Globulin Intravenous Sales Market Share by Region
8.2 North America
8.2.1 North America Human Immune Globulin Intravenous Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Immune Globulin Intravenous Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Immune Globulin Intravenous Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Immune Globulin Intravenous Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Immune Globulin Intravenous Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Takeda
9.1.1 Takeda Human Immune Globulin Intravenous Basic Information
9.1.2 Takeda Human Immune Globulin Intravenous Product Overview
9.1.3 Takeda Human Immune Globulin Intravenous Product Market Performance
9.1.4 Takeda Business Overview
9.1.5 Takeda Human Immune Globulin Intravenous SWOT Analysis
9.1.6 Takeda Recent Developments
9.2 Grifols
9.2.1 Grifols Human Immune Globulin Intravenous Basic Information
9.2.2 Grifols Human Immune Globulin Intravenous Product Overview
9.2.3 Grifols Human Immune Globulin Intravenous Product Market Performance
9.2.4 Grifols Business Overview
9.2.5 Grifols Human Immune Globulin Intravenous SWOT Analysis
9.2.6 Grifols Recent Developments
9.3 CSL
9.3.1 CSL Human Immune Globulin Intravenous Basic Information
9.3.2 CSL Human Immune Globulin Intravenous Product Overview
9.3.3 CSL Human Immune Globulin Intravenous Product Market Performance
9.3.4 CSL Human Immune Globulin Intravenous SWOT Analysis
9.3.5 CSL Business Overview
9.3.6 CSL Recent Developments
9.4 Octapharma
9.4.1 Octapharma Human Immune Globulin Intravenous Basic Information
9.4.2 Octapharma Human Immune Globulin Intravenous Product Overview
9.4.3 Octapharma Human Immune Globulin Intravenous Product Market Performance
9.4.4 Octapharma Business Overview
9.4.5 Octapharma Recent Developments
9.5 Biotest
9.5.1 Biotest Human Immune Globulin Intravenous Basic Information
9.5.2 Biotest Human Immune Globulin Intravenous Product Overview
9.5.3 Biotest Human Immune Globulin Intravenous Product Market Performance
9.5.4 Biotest Business Overview
9.5.5 Biotest Recent Developments
9.6 Kedrion
9.6.1 Kedrion Human Immune Globulin Intravenous Basic Information
9.6.2 Kedrion Human Immune Globulin Intravenous Product Overview
9.6.3 Kedrion Human Immune Globulin Intravenous Product Market Performance
9.6.4 Kedrion Business Overview
9.6.5 Kedrion Recent Developments
9.7 Hualan Bio
9.7.1 Hualan Bio Human Immune Globulin Intravenous Basic Information
9.7.2 Hualan Bio Human Immune Globulin Intravenous Product Overview
9.7.3 Hualan Bio Human Immune Globulin Intravenous Product Market Performance
9.7.4 Hualan Bio Business Overview
9.7.5 Hualan Bio Recent Developments
9.8 CNBG
9.8.1 CNBG Human Immune Globulin Intravenous Basic Information
9.8.2 CNBG Human Immune Globulin Intravenous Product Overview
9.8.3 CNBG Human Immune Globulin Intravenous Product Market Performance
9.8.4 CNBG Business Overview
9.8.5 CNBG Recent Developments
9.9 Shanghai RAAS
9.9.1 Shanghai RAAS Human Immune Globulin Intravenous Basic Information
9.9.2 Shanghai RAAS Human Immune Globulin Intravenous Product Overview
9.9.3 Shanghai RAAS Human Immune Globulin Intravenous Product Market Performance
9.9.4 Shanghai RAAS Business Overview
9.9.5 Shanghai RAAS Recent Developments
9.10 CBPO
9.10.1 CBPO Human Immune Globulin Intravenous Basic Information
9.10.2 CBPO Human Immune Globulin Intravenous Product Overview
9.10.3 CBPO Human Immune Globulin Intravenous Product Market Performance
9.10.4 CBPO Business Overview
9.10.5 CBPO Recent Developments
9.11 LFB Group
9.11.1 LFB Group Human Immune Globulin Intravenous Basic Information
9.11.2 LFB Group Human Immune Globulin Intravenous Product Overview
9.11.3 LFB Group Human Immune Globulin Intravenous Product Market Performance
9.11.4 LFB Group Business Overview
9.11.5 LFB Group Recent Developments
9.12 BPL
9.12.1 BPL Human Immune Globulin Intravenous Basic Information
9.12.2 BPL Human Immune Globulin Intravenous Product Overview
9.12.3 BPL Human Immune Globulin Intravenous Product Market Performance
9.12.4 BPL Business Overview
9.12.5 BPL Recent Developments
9.13 Sichuan Yuanda Shuyang
9.13.1 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Basic Information
9.13.2 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product Overview
9.13.3 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product Market Performance
9.13.4 Sichuan Yuanda Shuyang Business Overview
9.13.5 Sichuan Yuanda Shuyang Recent Developments
10 HUMAN IMMUNE GLOBULIN INTRAVENOUS MARKET FORECAST BY REGION
10.1 Global Human Immune Globulin Intravenous Market Size Forecast
10.2 Global Human Immune Globulin Intravenous Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Immune Globulin Intravenous Market Size Forecast by Country
10.2.3 Asia Pacific Human Immune Globulin Intravenous Market Size Forecast by Region
10.2.4 South America Human Immune Globulin Intravenous Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Immune Globulin Intravenous by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Human Immune Globulin Intravenous Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Human Immune Globulin Intravenous by Type (2025-2030)
11.1.2 Global Human Immune Globulin Intravenous Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Human Immune Globulin Intravenous by Type (2025-2030)
11.2 Global Human Immune Globulin Intravenous Market Forecast by Application (2025-2030)
11.2.1 Global Human Immune Globulin Intravenous Sales (Kilotons) Forecast by Application
11.2.2 Global Human Immune Globulin Intravenous Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Immune Globulin Intravenous Market Size Comparison by Region (M USD)
Table 5. Global Human Immune Globulin Intravenous Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Human Immune Globulin Intravenous Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Human Immune Globulin Intravenous Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Human Immune Globulin Intravenous Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immune Globulin Intravenous as of 2022)
Table 10. Global Market Human Immune Globulin Intravenous Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Human Immune Globulin Intravenous Sales Sites and Area Served
Table 12. Manufacturers Human Immune Globulin Intravenous Product Type
Table 13. Global Human Immune Globulin Intravenous Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Immune Globulin Intravenous
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Immune Globulin Intravenous Market Challenges
Table 22. Global Human Immune Globulin Intravenous Sales by Type (Kilotons)
Table 23. Global Human Immune Globulin Intravenous Market Size by Type (M USD)
Table 24. Global Human Immune Globulin Intravenous Sales (Kilotons) by Type (2019-2024)
Table 25. Global Human Immune Globulin Intravenous Sales Market Share by Type (2019-2024)
Table 26. Global Human Immune Globulin Intravenous Market Size (M USD) by Type (2019-2024)
Table 27. Global Human Immune Globulin Intravenous Market Size Share by Type (2019-2024)
Table 28. Global Human Immune Globulin Intravenous Price (USD/Ton) by Type (2019-2024)
Table 29. Global Human Immune Globulin Intravenous Sales (Kilotons) by Application
Table 30. Global Human Immune Globulin Intravenous Market Size by Application
Table 31. Global Human Immune Globulin Intravenous Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Human Immune Globulin Intravenous Sales Market Share by Application (2019-2024)
Table 33. Global Human Immune Globulin Intravenous Sales by Application (2019-2024) & (M USD)
Table 34. Global Human Immune Globulin Intravenous Market Share by Application (2019-2024)
Table 35. Global Human Immune Globulin Intravenous Sales Growth Rate by Application (2019-2024)
Table 36. Global Human Immune Globulin Intravenous Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Human Immune Globulin Intravenous Sales Market Share by Region (2019-2024)
Table 38. North America Human Immune Globulin Intravenous Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Human Immune Globulin Intravenous Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Human Immune Globulin Intravenous Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Human Immune Globulin Intravenous Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Human Immune Globulin Intravenous Sales by Region (2019-2024) & (Kilotons)
Table 43. Takeda Human Immune Globulin Intravenous Basic Information
Table 44. Takeda Human Immune Globulin Intravenous Product Overview
Table 45. Takeda Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Takeda Business Overview
Table 47. Takeda Human Immune Globulin Intravenous SWOT Analysis
Table 48. Takeda Recent Developments
Table 49. Grifols Human Immune Globulin Intravenous Basic Information
Table 50. Grifols Human Immune Globulin Intravenous Product Overview
Table 51. Grifols Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Grifols Business Overview
Table 53. Grifols Human Immune Globulin Intravenous SWOT Analysis
Table 54. Grifols Recent Developments
Table 55. CSL Human Immune Globulin Intravenous Basic Information
Table 56. CSL Human Immune Globulin Intravenous Product Overview
Table 57. CSL Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. CSL Human Immune Globulin Intravenous SWOT Analysis
Table 59. CSL Business Overview
Table 60. CSL Recent Developments
Table 61. Octapharma Human Immune Globulin Intravenous Basic Information
Table 62. Octapharma Human Immune Globulin Intravenous Product Overview
Table 63. Octapharma Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Octapharma Business Overview
Table 65. Octapharma Recent Developments
Table 66. Biotest Human Immune Globulin Intravenous Basic Information
Table 67. Biotest Human Immune Globulin Intravenous Product Overview
Table 68. Biotest Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Biotest Business Overview
Table 70. Biotest Recent Developments
Table 71. Kedrion Human Immune Globulin Intravenous Basic Information
Table 72. Kedrion Human Immune Globulin Intravenous Product Overview
Table 73. Kedrion Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Kedrion Business Overview
Table 75. Kedrion Recent Developments
Table 76. Hualan Bio Human Immune Globulin Intravenous Basic Information
Table 77. Hualan Bio Human Immune Globulin Intravenous Product Overview
Table 78. Hualan Bio Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Hualan Bio Business Overview
Table 80. Hualan Bio Recent Developments
Table 81. CNBG Human Immune Globulin Intravenous Basic Information
Table 82. CNBG Human Immune Globulin Intravenous Product Overview
Table 83. CNBG Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. CNBG Business Overview
Table 85. CNBG Recent Developments
Table 86. Shanghai RAAS Human Immune Globulin Intravenous Basic Information
Table 87. Shanghai RAAS Human Immune Globulin Intravenous Product Overview
Table 88. Shanghai RAAS Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Shanghai RAAS Business Overview
Table 90. Shanghai RAAS Recent Developments
Table 91. CBPO Human Immune Globulin Intravenous Basic Information
Table 92. CBPO Human Immune Globulin Intravenous Product Overview
Table 93. CBPO Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. CBPO Business Overview
Table 95. CBPO Recent Developments
Table 96. LFB Group Human Immune Globulin Intravenous Basic Information
Table 97. LFB Group Human Immune Globulin Intravenous Product Overview
Table 98. LFB Group Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. LFB Group Business Overview
Table 100. LFB Group Recent Developments
Table 101. BPL Human Immune Globulin Intravenous Basic Information
Table 102. BPL Human Immune Globulin Intravenous Product Overview
Table 103. BPL Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. BPL Business Overview
Table 105. BPL Recent Developments
Table 106. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Basic Information
Table 107. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product Overview
Table 108. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Sichuan Yuanda Shuyang Business Overview
Table 110. Sichuan Yuanda Shuyang Recent Developments
Table 111. Global Human Immune Globulin Intravenous Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Human Immune Globulin Intravenous Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Human Immune Globulin Intravenous Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Human Immune Globulin Intravenous Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Human Immune Globulin Intravenous Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Human Immune Globulin Intravenous Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Human Immune Globulin Intravenous Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Human Immune Globulin Intravenous Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Human Immune Globulin Intravenous Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Human Immune Globulin Intravenous Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Human Immune Globulin Intravenous Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Human Immune Globulin Intravenous Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Human Immune Globulin Intravenous Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Human Immune Globulin Intravenous Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Human Immune Globulin Intravenous Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Human Immune Globulin Intravenous Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Human Immune Globulin Intravenous Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Immune Globulin Intravenous Market Size Comparison by Region (M USD)
Table 5. Global Human Immune Globulin Intravenous Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Human Immune Globulin Intravenous Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Human Immune Globulin Intravenous Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Human Immune Globulin Intravenous Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immune Globulin Intravenous as of 2022)
Table 10. Global Market Human Immune Globulin Intravenous Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Human Immune Globulin Intravenous Sales Sites and Area Served
Table 12. Manufacturers Human Immune Globulin Intravenous Product Type
Table 13. Global Human Immune Globulin Intravenous Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Immune Globulin Intravenous
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Immune Globulin Intravenous Market Challenges
Table 22. Global Human Immune Globulin Intravenous Sales by Type (Kilotons)
Table 23. Global Human Immune Globulin Intravenous Market Size by Type (M USD)
Table 24. Global Human Immune Globulin Intravenous Sales (Kilotons) by Type (2019-2024)
Table 25. Global Human Immune Globulin Intravenous Sales Market Share by Type (2019-2024)
Table 26. Global Human Immune Globulin Intravenous Market Size (M USD) by Type (2019-2024)
Table 27. Global Human Immune Globulin Intravenous Market Size Share by Type (2019-2024)
Table 28. Global Human Immune Globulin Intravenous Price (USD/Ton) by Type (2019-2024)
Table 29. Global Human Immune Globulin Intravenous Sales (Kilotons) by Application
Table 30. Global Human Immune Globulin Intravenous Market Size by Application
Table 31. Global Human Immune Globulin Intravenous Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Human Immune Globulin Intravenous Sales Market Share by Application (2019-2024)
Table 33. Global Human Immune Globulin Intravenous Sales by Application (2019-2024) & (M USD)
Table 34. Global Human Immune Globulin Intravenous Market Share by Application (2019-2024)
Table 35. Global Human Immune Globulin Intravenous Sales Growth Rate by Application (2019-2024)
Table 36. Global Human Immune Globulin Intravenous Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Human Immune Globulin Intravenous Sales Market Share by Region (2019-2024)
Table 38. North America Human Immune Globulin Intravenous Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Human Immune Globulin Intravenous Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Human Immune Globulin Intravenous Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Human Immune Globulin Intravenous Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Human Immune Globulin Intravenous Sales by Region (2019-2024) & (Kilotons)
Table 43. Takeda Human Immune Globulin Intravenous Basic Information
Table 44. Takeda Human Immune Globulin Intravenous Product Overview
Table 45. Takeda Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Takeda Business Overview
Table 47. Takeda Human Immune Globulin Intravenous SWOT Analysis
Table 48. Takeda Recent Developments
Table 49. Grifols Human Immune Globulin Intravenous Basic Information
Table 50. Grifols Human Immune Globulin Intravenous Product Overview
Table 51. Grifols Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Grifols Business Overview
Table 53. Grifols Human Immune Globulin Intravenous SWOT Analysis
Table 54. Grifols Recent Developments
Table 55. CSL Human Immune Globulin Intravenous Basic Information
Table 56. CSL Human Immune Globulin Intravenous Product Overview
Table 57. CSL Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. CSL Human Immune Globulin Intravenous SWOT Analysis
Table 59. CSL Business Overview
Table 60. CSL Recent Developments
Table 61. Octapharma Human Immune Globulin Intravenous Basic Information
Table 62. Octapharma Human Immune Globulin Intravenous Product Overview
Table 63. Octapharma Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Octapharma Business Overview
Table 65. Octapharma Recent Developments
Table 66. Biotest Human Immune Globulin Intravenous Basic Information
Table 67. Biotest Human Immune Globulin Intravenous Product Overview
Table 68. Biotest Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Biotest Business Overview
Table 70. Biotest Recent Developments
Table 71. Kedrion Human Immune Globulin Intravenous Basic Information
Table 72. Kedrion Human Immune Globulin Intravenous Product Overview
Table 73. Kedrion Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Kedrion Business Overview
Table 75. Kedrion Recent Developments
Table 76. Hualan Bio Human Immune Globulin Intravenous Basic Information
Table 77. Hualan Bio Human Immune Globulin Intravenous Product Overview
Table 78. Hualan Bio Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Hualan Bio Business Overview
Table 80. Hualan Bio Recent Developments
Table 81. CNBG Human Immune Globulin Intravenous Basic Information
Table 82. CNBG Human Immune Globulin Intravenous Product Overview
Table 83. CNBG Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. CNBG Business Overview
Table 85. CNBG Recent Developments
Table 86. Shanghai RAAS Human Immune Globulin Intravenous Basic Information
Table 87. Shanghai RAAS Human Immune Globulin Intravenous Product Overview
Table 88. Shanghai RAAS Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Shanghai RAAS Business Overview
Table 90. Shanghai RAAS Recent Developments
Table 91. CBPO Human Immune Globulin Intravenous Basic Information
Table 92. CBPO Human Immune Globulin Intravenous Product Overview
Table 93. CBPO Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. CBPO Business Overview
Table 95. CBPO Recent Developments
Table 96. LFB Group Human Immune Globulin Intravenous Basic Information
Table 97. LFB Group Human Immune Globulin Intravenous Product Overview
Table 98. LFB Group Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. LFB Group Business Overview
Table 100. LFB Group Recent Developments
Table 101. BPL Human Immune Globulin Intravenous Basic Information
Table 102. BPL Human Immune Globulin Intravenous Product Overview
Table 103. BPL Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. BPL Business Overview
Table 105. BPL Recent Developments
Table 106. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Basic Information
Table 107. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product Overview
Table 108. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Sichuan Yuanda Shuyang Business Overview
Table 110. Sichuan Yuanda Shuyang Recent Developments
Table 111. Global Human Immune Globulin Intravenous Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Human Immune Globulin Intravenous Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Human Immune Globulin Intravenous Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Human Immune Globulin Intravenous Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Human Immune Globulin Intravenous Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Human Immune Globulin Intravenous Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Human Immune Globulin Intravenous Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Human Immune Globulin Intravenous Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Human Immune Globulin Intravenous Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Human Immune Globulin Intravenous Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Human Immune Globulin Intravenous Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Human Immune Globulin Intravenous Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Human Immune Globulin Intravenous Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Human Immune Globulin Intravenous Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Human Immune Globulin Intravenous Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Human Immune Globulin Intravenous Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Human Immune Globulin Intravenous Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Human Immune Globulin Intravenous
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Immune Globulin Intravenous Market Size (M USD), 2019-2030
Figure 5. Global Human Immune Globulin Intravenous Market Size (M USD) (2019-2030)
Figure 6. Global Human Immune Globulin Intravenous Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Immune Globulin Intravenous Market Size by Country (M USD)
Figure 11. Human Immune Globulin Intravenous Sales Share by Manufacturers in 2023
Figure 12. Global Human Immune Globulin Intravenous Revenue Share by Manufacturers in 2023
Figure 13. Human Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Immune Globulin Intravenous Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Immune Globulin Intravenous Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Immune Globulin Intravenous Market Share by Type
Figure 18. Sales Market Share of Human Immune Globulin Intravenous by Type (2019-2024)
Figure 19. Sales Market Share of Human Immune Globulin Intravenous by Type in 2023
Figure 20. Market Size Share of Human Immune Globulin Intravenous by Type (2019-2024)
Figure 21. Market Size Market Share of Human Immune Globulin Intravenous by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Immune Globulin Intravenous Market Share by Application
Figure 24. Global Human Immune Globulin Intravenous Sales Market Share by Application (2019-2024)
Figure 25. Global Human Immune Globulin Intravenous Sales Market Share by Application in 2023
Figure 26. Global Human Immune Globulin Intravenous Market Share by Application (2019-2024)
Figure 27. Global Human Immune Globulin Intravenous Market Share by Application in 2023
Figure 28. Global Human Immune Globulin Intravenous Sales Growth Rate by Application (2019-2024)
Figure 29. Global Human Immune Globulin Intravenous Sales Market Share by Region (2019-2024)
Figure 30. North America Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Human Immune Globulin Intravenous Sales Market Share by Country in 2023
Figure 32. U.S. Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Human Immune Globulin Intravenous Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Human Immune Globulin Intravenous Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Human Immune Globulin Intravenous Sales Market Share by Country in 2023
Figure 37. Germany Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Human Immune Globulin Intravenous Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Human Immune Globulin Intravenous Sales Market Share by Region in 2023
Figure 44. China Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Human Immune Globulin Intravenous Sales and Growth Rate (Kilotons)
Figure 50. South America Human Immune Globulin Intravenous Sales Market Share by Country in 2023
Figure 51. Brazil Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Human Immune Globulin Intravenous Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Human Immune Globulin Intravenous Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Human Immune Globulin Intravenous Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Human Immune Globulin Intravenous Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Human Immune Globulin Intravenous Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Human Immune Globulin Intravenous Market Share Forecast by Type (2025-2030)
Figure 65. Global Human Immune Globulin Intravenous Sales Forecast by Application (2025-2030)
Figure 66. Global Human Immune Globulin Intravenous Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Human Immune Globulin Intravenous
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Immune Globulin Intravenous Market Size (M USD), 2019-2030
Figure 5. Global Human Immune Globulin Intravenous Market Size (M USD) (2019-2030)
Figure 6. Global Human Immune Globulin Intravenous Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Immune Globulin Intravenous Market Size by Country (M USD)
Figure 11. Human Immune Globulin Intravenous Sales Share by Manufacturers in 2023
Figure 12. Global Human Immune Globulin Intravenous Revenue Share by Manufacturers in 2023
Figure 13. Human Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Immune Globulin Intravenous Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Immune Globulin Intravenous Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Immune Globulin Intravenous Market Share by Type
Figure 18. Sales Market Share of Human Immune Globulin Intravenous by Type (2019-2024)
Figure 19. Sales Market Share of Human Immune Globulin Intravenous by Type in 2023
Figure 20. Market Size Share of Human Immune Globulin Intravenous by Type (2019-2024)
Figure 21. Market Size Market Share of Human Immune Globulin Intravenous by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Immune Globulin Intravenous Market Share by Application
Figure 24. Global Human Immune Globulin Intravenous Sales Market Share by Application (2019-2024)
Figure 25. Global Human Immune Globulin Intravenous Sales Market Share by Application in 2023
Figure 26. Global Human Immune Globulin Intravenous Market Share by Application (2019-2024)
Figure 27. Global Human Immune Globulin Intravenous Market Share by Application in 2023
Figure 28. Global Human Immune Globulin Intravenous Sales Growth Rate by Application (2019-2024)
Figure 29. Global Human Immune Globulin Intravenous Sales Market Share by Region (2019-2024)
Figure 30. North America Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Human Immune Globulin Intravenous Sales Market Share by Country in 2023
Figure 32. U.S. Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Human Immune Globulin Intravenous Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Human Immune Globulin Intravenous Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Human Immune Globulin Intravenous Sales Market Share by Country in 2023
Figure 37. Germany Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Human Immune Globulin Intravenous Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Human Immune Globulin Intravenous Sales Market Share by Region in 2023
Figure 44. China Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Human Immune Globulin Intravenous Sales and Growth Rate (Kilotons)
Figure 50. South America Human Immune Globulin Intravenous Sales Market Share by Country in 2023
Figure 51. Brazil Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Human Immune Globulin Intravenous Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Human Immune Globulin Intravenous Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Human Immune Globulin Intravenous Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Human Immune Globulin Intravenous Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Human Immune Globulin Intravenous Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Human Immune Globulin Intravenous Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Human Immune Globulin Intravenous Market Share Forecast by Type (2025-2030)
Figure 65. Global Human Immune Globulin Intravenous Sales Forecast by Application (2025-2030)
Figure 66. Global Human Immune Globulin Intravenous Market Share Forecast by Application (2025-2030)
